Washington, DC 20006-5349
HELPLINE
The Congressionally Directed Medical Research Programs’ (CDMPR), Rare Cancers Research Program (RCRP) consumer advocate Jessica Blackford-Cleeton recently participated in the evaluation of research applications submitted…
Marjorie G. Zauderer, MD, discusses a currently enrolling Phase 1 clinical trial for mesothelioma patients. This CAR-T cell therapy trial targets mesothelin, a protein heavily…
Heather Von St James’ fifteenth annual Lung Leavin’ Day is virtually taking place Saturday, Feb. 6 to celebrate her 15 years of survivorship. Folks can join via Facebook…
Kanwal Raghav, MD, discusses the results of a Phase 2 trial of atezolizumab and bevacizumab in patients with relapsed/refractory and unresectable malignant peritoneal mesothelioma. Dr.…
The Mesothelioma Applied Research Foundation recommends Covid-19 vaccinations in mesothelioma patients receiving immunotherapy treatments. We commend the unprecedented development of safe, effective Covid-19 vaccines. It is our hope that these vaccines will end the pandemic, especially for our mesothelioma community…
You asked, we listened! As a result of your requests for more information about the legal process as it relates to mesothelioma, we bring you…
The Mesothelioma Applied Research Foundation has added a new monthly mesothelioma support group call for those who are under 55 and have lost a spouse to mesothelioma. Claudine Benmar and Gwen Dew,…
Bonnie Anderson is a 19-year mesothelioma survivor. She discusses her peritoneal mesothelioma diagnosis in 2002, her history with multiple cancers, and her family’s advocacy efforts…
As we thought about our 2020 year in review, we were, of course, reminded that this year was a time of extraordinary challenges for everyone.…
Despite 2020’s pandemic challenges, these Fundraise for Meso events raised much needed mesothelioma awareness and funds to support the Mesothelioma Applied Research Foundation. The Foundation is especially appreciative of these event organizers for their continued support and…
Get the latest information about mesothelioma, clinical trials, patient stories, community events, and much more!
